HOXC11 is a sequence-specific transcription factor that functions as part of a developmental regulatory system providing cells with positional identity along the anterior-posterior axis 1. During embryonic development, HOXC11 is expressed in the posterior neural tube, dorsal root ganglia, prevertebrae, hindlimbs, and developing kidney, with particularly prominent expression in posterior urogenital structures 1. The protein promotes cellular differentiation by transcriptionally activating specific target genes, as demonstrated by its ability to induce S100beta expression during neuroblastoma cell differentiation into Schwannian cells 2. In pathological contexts, HOXC11 functions as an oncogene across multiple cancer types. It is upregulated in colon adenocarcinoma and kidney renal clear cell carcinoma, where high expression correlates with poor overall survival and promotes cell proliferation through inactivation of the PPARγ signaling pathway 3. In renal cell carcinoma, HOXC11 overexpression enhances proliferation and correlates with advanced tumor stage and shorter survival 4. The transcription factor also drives lung adenocarcinoma progression by directly binding to and upregulating SPHK1 5, while in ovarian cancer, it promotes tumorigenesis through transcriptional regulation of PROM2 and activation of the PI3K/AKT pathway 6. These findings establish HOXC11 as both a critical developmental regulator and significant oncogenic driver.